[
    [
        {
            "time": "2018-03-15",
            "original_text": "PacBio (PACB)-UCLA Health Tie Up for Rare Diseases WGS Research",
            "features": {
                "keywords": [
                    "PacBio",
                    "UCLA",
                    "Health",
                    "Rare Diseases",
                    "WGS Research"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "PacBio (PACB)-UCLA Health Tie Up for Rare Diseases WGS Research",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-04-20",
            "original_text": "OPKO Health (OPK) Receives FDA Nod for the 4Kscore Test",
            "features": {
                "keywords": [
                    "OPKO Health",
                    "FDA",
                    "4Kscore Test"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "diagnostics"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-05-10",
            "original_text": "How Many Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Do Institutions Own?",
            "features": {
                "keywords": [
                    "Thermo Fisher",
                    "Institutions",
                    "Shares"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "industrial goods",
                    "life sciences"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 2,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-06-05",
            "original_text": "Exact Sciences (EXAS) Oncotype DX Test Study Data Favorable",
            "features": {
                "keywords": [
                    "Exact Sciences",
                    "Oncotype DX",
                    "Study Data",
                    "Favorable"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "cancer diagnostics"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Exact Sciences (EXAS) Oncotype DX Test Study Data Favorable",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-07-12",
            "original_text": "Top 10 Stock Picks of Ryan Caldwellâ€™s Chiron Investment",
            "features": {
                "keywords": [
                    "Stock Picks",
                    "Ryan Caldwell",
                    "Chiron Investment"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "diverse sectors"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 2,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]